GENTA INCORPORATED /DE/
5, 2000-03-29
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: SMITH BARNEY INVESTMENT TRUST, 485BPOS, 2000-03-29
Next: DREYFUS FLORIDA INTERMEDIATE MUNICIPAL BOND FUND, 497, 2000-03-29




UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 5

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).

1. Name and Address of Reporting Person

     Klem, Robert E.
     c/o Genta Incorporated
     99 Hayden Avenue, Suite 200
     Lexington, MA  02421

2. Issuer Name and Ticker or Trading Symbol

   Genta Incorporated, GNTA

3. IRS or Social Security Number of Reporting Person (Voluntary)

4. Statement for Month/Year
   12/99

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)

   (X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other  (specify
   below)

7. Individual or Joint/Group Filing (Check Applicable Line)

   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
- -----------------------------------------------------------------------------------------------------------------------------------|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
<S>                         <C>    <C> <C>  <C>             <C>   <C>        <C>                 <C>    <C>
Common Stock, par value    |8/20/ | X4 | |    24,000        | A |  $.94375  |  646,153          |  D   |     D                     |
$.001                      |99    |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value    |8/20/ | S4 | |    24,000        | D |  $.94375  |  622,153          |  D   |     D                     |
$.001                      |99    |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value    |11/29/| X4 | |    21,483        | A |  $.94375  |  622,153          |  D   |     D                     |
$.001                      |99    |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value    |11/29/| S4 | |    21,483        | D |  $.94375  |  600,670          |  D   |     D                     |
$.001                      |99    |    | |                  |   |           |                   |      |                           |
- -----------------------------------------------------------------------------------------------------------------------------------|
</TABLE>

Reminder:  Report on a separate line for each class of  securities  beneficially
owned directly or indirectly.

* If the form is  filed  by more  than one  reporting  person,  see  Instruction
4(b)(v).

                                                                         (Over)
                                                    SEC 1474 (7-96) Page 1 of 2

<PAGE>
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------------------------------------------------------------
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
- -----------------------------------------------------------------------------------------------------------------------------------|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |          |    |Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |          |A/D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount  |    |ble  |     |                    |       |Month       |(I)|            |
- -----------------------------------------------------------------------------------------------------------------------------------|
<S>                    <C>      <C>   <C> <C> <C>      <C>  <C>  <C>     <C>          <C>     <C>     <C>         <C>  <C>
Options (right to buy |$.94375 |8/20 | X4 | |          |24, |3/  |10/31/|Comon Stock,|24,000 | (1)   | 622,153    |D  |  D         |
                      |        |99   |    | |          |000 |31  |07    |par value   |       |       |            |   |            |
                      |        |     |    | |          |(D) |99  |      |$.001       |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Options (right to buy |$.94375 |11/29| X4 | |          |21, |3/  |10/31/|Comon Stock,|21,483 | (1)   | 600,670    |D  |  D         |
                      |        |99   |    | |          |483 |31  |07    |par value   |       |       |            |   |            |
                      |        |     |    | |          |(D) |99  |      |$.001       |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
</TABLE>

Explanation of Responses:

(1) Acquired under the Genta Incorporated 1998 Stock Incentive Plan

** Intentional misstatements or omissions of facts constitute Federal Criminal
   Violations.
   See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note:   File three copies of this Form, one of which must be manually signed.
        If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.

                          /s/ Robert E. Klem                  March 29, 2000
                          ------------------                  ----------------
                          Robert E. Klem                      Date
                          ** Signature of Reporting Person

Potential persons who are to respond to the collection of information  contained
in this form are not  required to respond  unless the form  displays a currently
valid OMB Number.
                                                                 SEC 1474 (7-96)
                                                                    Page 2 of 2




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission